Skip to Content

American Association for Cancer Research (AACR)

myAACR
Donate Today
FDA Approvals

The U.S. Food and Drug Administration recently expanded the use of a molecularly targeted therapeutic to include the treatment of certain patients with metastatic prostate cancer.

Learn More
About Cancer
About Cancer

Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.

Learn More
FDA Approvals
FDA Approvals

A combination of two immunotherapeutics has been approved to treat certain patients with non-small cell lung cancer, the most common type of lung cancer.

Learn More
May is National Cancer Research Month
May is National Cancer Research Month

Join the AACR in honoring all the researchers driving progress against cancer. #NCRM20 #ResearchSavesLives

Learn More
Cancer Types
Cancer Types

Lung cancer is the most common type of cancer with nearly 229,000 people living in the United States expected to be diagnosed this year. Learn about prevention, screening, and treatment options for lung cancer.

Learn More
From the Blog
From the Blog

An AACR grantee has identified a novel combination therapy for epithelial ovarian cancer.

Learn More
Get Involved
Get Involved

Join the AACR Runners for Research and support lifesaving cancer research by participating in virtual races and events around the country. Join the team as a virtual runner or create your own event.

Learn More
For Researchers
For Researchers
AACR Virtual Annual Meeting II

June 22-24
Registration for this virtual meeting, featuring a complete educational program as well as approximately 4,000 proffered papers on an e-poster platform, is free.

Register Now

Videos
Driving Progress Against Cancer

The American Association for Cancer Research (AACR) and our more than 47,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.

Learn More
Keeping Breast Cancer at Bay with Immunotherapy

Eva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.

Learn More
Charles L. Sawyers, MD: Fellow of the AACR Academy

A physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.

Learn More
More Videos
By the Numbers
16.9

million cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research

Learn More
4 in 10

cancer diagnoses in the United States are associated with preventable risk factors

Learn More
17

new therapeutics against cancer were approved by the FDA from August 1, 2018, to July 31, 2019

Learn More
27.5

million people are projected to be diagnosed with cancer worldwide by the year 2040

Learn More
For more statistics on cancer, please visit our Cancer Progress ReportRead the AACR Cancer Progress Report